Article · 27 Dec 2024
Review articlePublished 10 Oct 2017
Potential Disadvantages Associated with Treatment of ActiveTuberculosis Using Fixed-Dose Combination: A Review of Literature
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and Objectives: Prevalence of Tuberculosis (TB) is quite high in various regions of the world. Fixed-dose combination (FDC) is highly recommended in various cases like TB, diabetes mellitus, hypertension, etc. Various studies are conducted to assess safety and efficacy of FDC. Likewise, prime focus of present review is to evaluate the potential disadvantages of FDC and compare it with single formulation (SF). Methods: We used a number of electronic databases to identify the relevant published studies which demonstrated the disadvantages regarding fixed dose combination for tuberculosis. Of 204 articles found initially, 143 were selected for additional review. Subsequently, 72 articles were finally selected. Results and Conclusions: Being a disease of poor, several advantages like cost-effectiveness, reduction in pill burden and logistical advantages, etc. can be achieved with FDC. Besides these advantages, there are several disadvantages like poor bioavailability, enzyme level elevation, adverse drug reactions, questionable effectiveness in the absence of Direct Observed Therapy Short course (DOTS) and therapeutic drug monitoring, difficulty in dose adjustment, etc. are associated with FDC. In such consequences there may be the need to reconsider the treatment regimen, otherwise conversion of TB into multi-drug resistant TB (MDR-TB) or extended drug resistant TB (XDR TB) occurs. Hence, it is concluded that FDC is neither superior nor inferior in terms of clinical outcomes and in certain situations the need of SF might not be replaced by FDC.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Basic and Clinical Pharmacy.
Article · 27 Dec 2024
The Role of Binder Selection in Optimizing Tablet Strength and Dissolution
Article · 27 Dec 2024
Pharmacy-Based Interventions for Improving Maternal and Child Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Basic and Clinical Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sadia Iftikhar”
- BylineArticles whose byline prints “Muhammad Rehan Sarwar”